Cosentyx 150 mg / 1 ml
Cosentyx 150 mg / 1 ml is a medicine authorised by Swissmedic under authorisation number 65225. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 20 February 2015 and the authorisation is valid without a time limit. ATC code L04AC10 places the medicine in the group Immunosuppressants.
| Authorisation number | 65225 |
|---|---|
| Name | Cosentyx 150 mg / 1 ml |
| Full name | Cosentyx 150 mg / 1 ml, Injektionslösung in einer Fertigspritze |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AC10 |
| First authorisation | 20 February 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Cosentyx 150 mg / 1 ml, Injektionslösung in einer Fertigspritze | B | 20 February 2015 |
| 2 | Cosentyx 300 mg / 2 ml, Injektionslösung in einer Fertigspritze | B | 03 February 2022 |
| 3 | Cosentyx 75 mg / 0.5 ml, Injektionslösung in einer Fertigspritze | B | 13 April 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | L04AC10 | 07.15.0. | B |
| 2 | 2 | Fertigspritze(n) | L04AC10 | 07.15.0. | B |
| 3 | 1 | Fertigspritze(n) | L04AC10 | 07.15.0. | B |
| 4 | 1 | Fertigspritze(n) | L04AC10 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Cosentyx 150 mg / 1 ml authorised in Switzerland?
Yes. Cosentyx 150 mg / 1 ml is authorised by Swissmedic under authorisation number 65225, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Cosentyx 150 mg / 1 ml have?
Cosentyx 150 mg / 1 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Cosentyx 150 mg / 1 ml?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.